CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI Potential protective mechanisms of green tea polyphenol EGCG against COVID-19 3D Printing and Heart Failure: The Present and the Future Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site Results From the EXCEL Trial

Guideline2014 Jun 24;129(25 Suppl 2):S49-73.

JOURNAL:Circulation. Article Link

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Goff DC Jr, Lloyd-Jones DM, American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Keywords: AHA Scientific Statements; biomarkers; cardiovascular disease; cholesterol; primary prevention; risk assessment; risk reduction behavior

Full Text PDF